|
2026-05-20 |
2025-05-18 |
B
Purchase
|
Non-Executive Director
|
76,003
+21.8%
67.02
US$1,332,460
|
76,003
+21.8%
|
67.02
|
US$1,332,460
|
|
|
2024-12-12 |
2024-12-10 |
S
Sale
|
Non-Executive Director
|
28,351
+37.3%
345.80
US$3,417,050
|
28,351
+37.3%
|
345.80
|
US$3,417,050
|
|
|
2024-12-10 |
2024-12-10 |
PrS
Proposed sale
|
Lead Independent Director
Non-Executive Director
|
57,426
310.65
US$680,021
|
57,426
|
310.65
|
US$680,021
|
|
|
2024-09-19 |
2024-09-19 |
PrS
Proposed sale
|
Affiliate
|
1,841
4.00
US$7,367
|
1,841
|
4.00
|
US$7,367
|
|
|
2024-09-19 |
2024-09-19 |
S
Sale
|
President, CEO, and Chairman
Executive Director
|
1,841
-0.0%
4.00
US$7,367
|
1,841
-0.0%
|
4.00
|
US$7,367
|
|
|
2024-09-19 |
2024-09-18 |
S
Sale
|
President, CEO, and Chairman
Executive Director
|
22,187
-0.4%
4.03
US$89,469
|
22,187
-0.4%
|
4.03
|
US$89,469
|
|
|
2024-09-18 |
2024-09-18 |
PrS
Proposed sale
|
Affiliate
|
22,187
4.03
US$89,469
|
22,187
|
4.03
|
US$89,469
|
|
|
2024-09-19 |
2024-09-17 |
S
Sale
|
President, CEO, and Chairman
Executive Director
|
33,941
-0.6%
4.05
US$137,318
|
33,941
-0.6%
|
4.05
|
US$137,318
|
|
|
2024-09-17 |
2024-09-17 |
PrS
Proposed sale
|
Affiliate
|
33,941
4.05
US$137,318
|
33,941
|
4.05
|
US$137,318
|
|
|
2024-06-21 |
2024-06-20 |
S
Sale
|
Non-Executive Director
|
17,544
-21.1%
3.49
US$61,144
|
17,544
-21.1%
|
3.49
|
US$61,144
|
|
|
2024-06-20 |
2024-06-20 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
17,544
3.92
US$68,772
|
17,544
|
3.92
|
US$68,772
|
|
|
2024-06-07 |
2024-06-05 |
S
Sale
|
President, CEO, and Chairman
Executive Director
|
1,006
-0.0%
4.00
US$4,024
|
1,006
-0.0%
|
4.00
|
US$4,024
|
|
|
2024-06-05 |
2024-06-05 |
PrS
Proposed sale
|
Affiliate
|
1,006
4.00
US$4,024
|
1,006
|
4.00
|
US$4,024
|
|
|
2024-02-02 |
2024-02-01 |
PlS
Planned sale
|
Chief Development Officer
Officer
|
14,029
-28.4%
3.84
US$53,913
|
14,029
-28.4%
|
3.84
|
US$53,913
|
|
|
2024-02-02 |
2024-02-01 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
15,870
-38.2%
3.84
US$60,963
|
15,870
-38.2%
|
3.84
|
US$60,963
|
|
|
2024-02-02 |
2024-02-01 |
PlS
Planned sale
|
EVP, Chief Accounting Officer
Officer
|
12,477
-37.4%
3.84
US$47,904
|
12,477
-37.4%
|
3.84
|
US$47,904
|
|
|
2024-02-02 |
2024-02-01 |
PlS
Planned sale
|
President, CEO, and Chairman
Executive Director
|
56,910
-32.8%
3.85
US$218,819
|
56,910
-32.8%
|
3.85
|
US$218,819
|
|
|
2024-02-02 |
2024-02-01 |
PlS
Planned sale
|
See Remarks
Officer
|
15,843
-2.3%
3.84
US$60,915
|
15,843
-2.3%
|
3.84
|
US$60,915
|
|
|
2024-02-02 |
2024-02-01 |
PlS
Planned sale
|
Chief Commercial Officer
Officer
|
11,819
-35.5%
3.84
US$45,420
|
11,819
-35.5%
|
3.84
|
US$45,420
|
|
|
2024-02-01 |
2024-02-01 |
PrS
Proposed sale
|
EVP, Chief Accounting Officer
Officer
|
14,311
4.07
US$58,246
|
14,311
|
4.07
|
US$58,246
|
|
|
2024-02-01 |
2024-02-01 |
PrS
Proposed sale
|
President, CEO, and Chairman
|
65,476
4.07
US$266,487
|
65,476
|
4.07
|
US$266,487
|
|
|
2024-02-01 |
2024-02-01 |
PrS
Proposed sale
|
Chief Development Officer
Officer
|
16,110
4.07
US$65,568
|
16,110
|
4.07
|
US$65,568
|
|
|
2024-02-01 |
2024-02-01 |
PrS
Proposed sale
|
Chief Commercial Officer
Officer
|
13,552
4.07
US$55,157
|
13,552
|
4.07
|
US$55,157
|
|
|
2024-02-01 |
2024-02-01 |
PrS
Proposed sale
|
Chief Medical Officer
Officer
|
18,227
4.07
US$74,184
|
18,227
|
4.07
|
US$74,184
|
|
|
2024-02-01 |
2024-02-01 |
PrS
Proposed sale
|
CFO, EVP, Legal and Secretary
|
18,198
4.07
US$74,066
|
18,198
|
4.07
|
US$74,066
|
|
|
2022-11-15 |
2022-11-14 |
S
Sale
|
Non-Executive Director
|
16,166
-2.0%
5.16
US$83,352
|
16,166
-2.0%
|
5.16
|
US$83,352
|
|
|
2022-11-15 |
2022-11-11 |
S
Sale
|
Non-Executive Director
|
25,500
-3.1%
5.15
US$131,333
|
25,500
-3.1%
|
5.15
|
US$131,333
|
|
|
2021-12-21 |
2021-12-20 |
B
Purchase
|
Non-Executive Director
|
12,000
+106.2%
8.57
US$102,796
|
12,000
+106.2%
|
8.57
|
US$102,796
|
|
|
2020-11-04 |
2020-11-03 |
B
Purchase
|
Large shareholder
|
7,292
+2.6%
24.00
US$175,008
|
7,292
+2.6%
|
24.00
|
US$175,008
|
|
|
2020-11-04 |
2020-11-03 |
B
Purchase
|
Large shareholder
|
242,708
+17.2%
24.00
US$5,824,992
|
242,708
+17.2%
|
24.00
|
US$5,824,992
|
|
|
2020-11-03 |
2020-11-03 |
B
Purchase
|
Non-Executive Director
|
41,666
+5.4%
24.00
US$999,984
|
41,666
+5.4%
|
24.00
|
US$999,984
|
|
|
2020-11-03 |
2020-11-03 |
B
Purchase
|
Non-Executive Director
|
250,000
+4.7%
24.00
US$6,000,000
|
250,000
+4.7%
|
24.00
|
US$6,000,000
|
|